Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.
Splinter
T A
TA
University Hospital Dijkzigt, Rotterdam, Dept. of Medical Oncology.
Denis
L
L
Scher
H I
HI
Schröder
F H
FH
Dalesio
O
O
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D009426:Netherlands; D011379:Prognosis; D014481:United States; D001743:Urinary Bladder / Q000601:surgery*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D014747:Vinblastine / Q000008:administration & dosage
D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate